Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Variations in the efficacy of TNP-470 according to the time of day administered

March 3, 2003

Efficacy reported for G-3139-containing chemotherapy in refractory/relapsed acute leukemia

March 3, 2003

Exelixis and Protein Design Labs' cancer antibody research collaboration progresses

March 3, 2003

New inhibitors of glyceraldehyde-3-phosphate dehydrogenase and their use in cancer

March 3, 2003

Xerion advances therapeutic antibody pipeline

Feb. 28, 2003

FDA approval for Gliadel Wafer during initial surgery for primary malignant glioma

Feb. 28, 2003

NeoRx submits phase II dosimetry results for skeletal targeted radiotherapy

Feb. 28, 2003

Praecis resubmits Plenaxis NDA

Feb. 28, 2003

Antiangiogenic activity of FYK-1388 demonstrated in vitro and in vivo

Feb. 27, 2003

Orphan medicinal product designation for Corixa's Bexxar product

Feb. 27, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...